Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Shares Outstanding (Weighted Average)
Others
Ratios

RedHill Biopharma (RDHL) Other Non Operating Income (2016 - 2019)

Historic Other Non Operating Income for RedHill Biopharma (RDHL) over the last 6 years, with Q4 2019 value amounting to -$8000.0.

  • RedHill Biopharma's Other Non Operating Income rose 9963.5% to -$8000.0 in Q4 2019 from the same period last year, while for Dec 2019 it was -$344000.0, marking a year-over-year decrease of 23076.92%. This contributed to the annual value of -$344000.0 for FY2019, which is 23076.92% down from last year.
  • According to the latest figures from Q4 2019, RedHill Biopharma's Other Non Operating Income is -$8000.0, which was up 9963.5% from -$5000.0 recorded in Q3 2019.
  • In the past 5 years, RedHill Biopharma's Other Non Operating Income ranged from a high of $1.7 million in Q3 2017 and a low of -$3.9 million during Q4 2017
  • Moreover, its 5-year median value for Other Non Operating Income was -$201000.0 (2016), whereas its average is -$507066.7.
  • In the last 5 years, RedHill Biopharma's Other Non Operating Income plummeted by 52786.07% in 2017 and then surged by 204600.0% in 2019.
  • Quarter analysis of 5 years shows RedHill Biopharma's Other Non Operating Income stood at -$248000.0 in 2015, then plummeted by 312.1% to -$1.0 million in 2016, then tumbled by 277.59% to -$3.9 million in 2017, then soared by 43.2% to -$2.2 million in 2018, then skyrocketed by 99.64% to -$8000.0 in 2019.
  • Its Other Non Operating Income stands at -$8000.0 for Q4 2019, versus -$5000.0 for Q3 2019 and -$1.3 million for Q2 2019.